4//SEC Filing
UNILENS VISION INC 4
Accession 0001513162-15-000550
CIK 0000852564operating
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 3:05 PM ET
Size
7.9 KB
Accession
0001513162-15-000550
Insider Transaction Report
Form 4
Bennett Nicholas
Director
Transactions
- Disposition to Issuer
Option to Buy Common Stock
2015-09-02−15,000→ 0 totalExercise: $7.92Exp: 2020-03-01→ Common Stock (15,000 underlying) - Disposition to Issuer
Common Stock
2015-09-02$12.75/sh−7,500$95,625→ 0 total
Footnotes (3)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, on July 10, 2015, by and among Valeant Pharmaceuticals International, a Delaware corporation ("Parent"), OneEye Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), and Unilens Vision Inc., a Delaware corporation (the "Issuer"), each share of the Issuer's stock issued and outstanding immediately prior to the Effective Time (as defined in the Agreement and Plan of Merger) was converted into the right to receive $12.75 per share in cash, subject to any applicable withholding taxes.
- [F2]Options are 100% vested.
- [F3]Pursuant to the terms of the Agreement and Plan of Merger, immediately prior to the Effective Time (as defined in the Agreement and Plan of Merger), each unexpired and unexercised option to purchase the Issuer's common stock, all of which were exercisable and vested, was cancelled and, in exchange therefor, each option holder became entitled to receive a cash payment equal to the product of (i) the total number of shares previously subject to such option and (ii) the excess of the merger consideration ($12.75 per share) over the exercise price of the option.
Documents
Issuer
UNILENS VISION INC
CIK 0000852564
Entity typeoperating
Related Parties
1- filerCIK 0000852564
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 3:05 PM ET
- Size
- 7.9 KB